A feasibility study of XELOX plus Ca/Mg and Goshajinkigan as adjuvant chemotherapy for colorectal cancer. (KSCC1201)
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2623313
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Oxaliplatin 130mg/m2 i.v. (day1) Capecitabine2,000mg/m2 ,p.o.(day1-14) Ca/Mg 0.8-1g/body i.v. x2 before and after L-OHP infusion (day1) Goshajinkigan 7.5g/body ,p.o.(day1-21) to be repeated every 3 weeks
Primary outcome(s): The rate of completion of treatment as planned
Study Design: Single arm Non-randomized
创建时间：
2012-05-15
